In vivo / preclinical – anti-infectives
In vivo services to find the next generation drugs that combat infectious disease
With the rising prevalence of drug-resistant microorganisms, effective and potent anti-infective agents are becoming increasingly more relevant in order to treat infectious diseases. Eurofins, through the expertise of Panlabs, identified this need over 25 years ago and has since been working diligently with the pharmaceutical industry to provide a robust portfolio of in vitro and in vivo anti-infective models to support the discovery and development of novel antimicrobial therapies.
Eurofins is dedicated to taking your anti-infective program from in vitro screens to preclinical testing. Our broad panel contains over 40 validated assays used to evaluate the efficacy of your drug candidates in infection models. Our validated methods are optimized for minimal data scatter and are demonstrated dose-responsive to standard antimicrobial agents. The models have been used to test small molecules, drug combinations, biologics, RNAi, liposomal formulations, nanoparticles, and vaccines.
Features of in vivo anti-infective services from Eurofins: